(2 references)-
- 抗原 See all Cytokeratin 5 (KRT5) 抗体
- Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))
-
适用
- 人
-
宿主
-
豚鼠
-
克隆类型
- 多克隆
-
标记
- This Cytokeratin 5 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- 纯度
- Stabilized antiserum
- 免疫原
- Cytokeratin 5 antibody was raised in guinea pig using recombinant human keratin K5 as the immunogen.
- Top Product
- Discover our top product KRT5 Primary Antibody
-
anti-Keratin 5 (KRT5) (AA 316-590) antibody
KRT5 适用: 人 WB, IHC, ELISA, FACS 宿主: 小鼠 Monoclonal 10C11E6 unconjugated
anti-Keratin 5 (KRT5) antibodyKRT5 适用: 人 WB, IHC, ELISA, FACS, ICC 宿主: 小鼠 Monoclonal 2C2 unconjugated
anti-Keratin 5 (KRT5) (AA 335-473) antibodyKRT5 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Keratin 5 (KRT5) (AA 316-590) antibodyKRT5 适用: 人 IHC, StM 宿主: 小鼠 Monoclonal KRT5-3594 unconjugated
anti-Keratin 5 (KRT5) (AA 1-273) antibodyKRT5 适用: 人 WB, IHC, IHC (p) 宿主: 小鼠 Monoclonal 4A7 unconjugated
anti-Keratin 5 (KRT5) antibodyKRT5 适用: 人 WB, IHC, IF, IP 宿主: 兔 Polyclonal unconjugated
anti-Keratin 5 (KRT5) (AA 258-357) antibodyKRT5 适用: 人 WB, IHC, ELISA, FACS, ICC 宿主: 小鼠 Monoclonal 2C8E4 unconjugated
anti-Keratin 5 (KRT5) (AA 331-430) antibodyKRT5 适用: 人, 小鼠, 大鼠 WB, ELISA, FACS, IHC (p), IF (cc), IF (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Keratin 5 (KRT5) (AA 163-471) antibodyKRT5 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Keratin 5 (KRT5) (AA 1-590) antibodyKRT5 适用: 人 WB, ELISA, IP 宿主: 小鼠 Monoclonal 1A12 unconjugated
-
- 应用备注
- IHC-F: 1:100, IHC-P: 1:50, WB: 1:5,000-1:10,000
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- Lot specific
- 缓冲液
- Suppleid as a liquid with 0.09 % NaN3 and 0.5 % BSA.
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
- 储存条件
- 4 °C
- 储存方法
- Store at 4 °C
-
-
: "Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4." in: Nature communications, Vol. 10, Issue 1, pp. 5546, (2020) (PubMed).
: "p73 regulates epidermal wound healing and induced keratinocyte programming." in: PLoS ONE, Vol. 14, Issue 6, pp. e0218458, (2019) (PubMed).
-
: "Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4." in: Nature communications, Vol. 10, Issue 1, pp. 5546, (2020) (PubMed).
-
- 抗原
- Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))
- 别名
- Cytokeratin 5 (KRT5 产品)
-
You are here:
